The primary objective is to examine the acute effect of color, room orientation (affecting amount of luminosity) on perceived health status and stress levels in oncologic patients during chemotherapy sessions at outpatient clinic. The secondary objectives will be to study the effect on vital signs (body temperature, heart rate, systolic blood pressure). Patients will be allocated into four conditions (Group A: Cold North, Group B: Cold South C: Warm North D: Warm South) for each session. For the next session, patients will be assigned a new condition. Assignment of sequences will be randomized for each patient. 20 patients will be randomly assigned to one of the four groups, after having signed the Free and Informed Consent Form and agreed to participate in the project, will respond to the evaluation form and will be submitted to physical examination. Patients will be treated per standard of care.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Enrollment
20
Rooms where chemotherapy sessions are delivered will be modified to show warm/cold color temperature in walls and equipment.
Room will be facing North or South
Hospital Ruber Internacional
Madrid, Spain
RECRUITINGEUROQOL-5D-5L questionnaire: Mobility
The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement using a 1-digit number that expresses the level selected for that dimension.
Time frame: 5 minutes before to 5 minutes after chemotherapy session
EUROQOL-5D-5L questionnaire: Self-care
The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement using a 1-digit number that expresses the level selected for that dimension.
Time frame: 5 minutes before to 5 minutes after chemotherapy session
EUROQOL-5D-5L questionnaire: Usual activities
The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement using a 1-digit number that expresses the level selected for that dimension.
Time frame: 5 minutes before to 5 minutes after chemotherapy session
EUROQOL-5D-5L questionnaire: Pain/Discomfort
The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement using a 1-digit number that expresses the level selected for that dimension.
Time frame: 5 minutes before to 5 minutes after chemotherapy session
EUROQOL-5D-5L questionnaire: Anxiety/Depression
The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement using a 1-digit number that expresses the level selected for that dimension.
Time frame: 5 minutes before to 5 minutes after chemotherapy session
EUROQOL-5D-5L questionnaire: EQ-VAS
The EQ VAS is an independent subscale of the EUROQOL-5D-5L questionnaire, which uses a vertical visual analogue scale format. The EQ VAS is used for recording the self-rated health on a range from 0 to 100, where the endpoints are labelled 'The best health you can imagine' (100) and 'The worst health you can imagine' (0). The VAS can be used as a quantitative measure of health outcome that reflect the patient's own judgement
Time frame: 5 minutes before to 5 minutes after chemotherapy session
ID-Pain questionnaire
Assessment of neuropathic pain
Time frame: 5 minutes before to 5 minutes after chemotherapy session
Vital signs: body temperature
Per standard of care, in Celsius
Time frame: 5 minutes before to 5 minutes after chemotherapy session
Vital signs: blood pressure
Per standard of care, in mm Hg
Time frame: 5 minutes before to 5 minutes after chemotherapy session
Vital signs: heart rate
Per standard of care, in beats per minute
Time frame: 5 minutes before to 5 minutes after chemotherapy session
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.